Recent News

• 02.13.2025 - Nutriband and Kindeva formalize exclusive product development partnership and long-term commitment based on shared development costs in exchange for milestone payments
• 02.11.2025 - Nutriband Inc. Announces Olympian Anastasia Nichita to Advisory Board
• 02.07.2025 - Nutriband Receives Notice Of Allowance For New U.S. Patent Covering Its Transdermal Abuse Deterrent Technology Aversa(TM)
• 01.06.2025 - Annual meeting of stockholders to be held January 23, 2025
• 12.31.2024 - Nutriband Issues Letter to Shareholders
• 12.27.2024 - Nutriband Extends Chinese Patent to Macao for its AVERSA™ Abuse Deterrent Transdermal Technology
• 12.10.2024 - Nutriband - NobleCon20 - Presentation Replay
• 12.04.2024 - Nutriband Inc. Announces Financial Results for the Third Quarter of 2024
• 11.21.2024 - Nutriband Inc. Issued Full Patent from the Chinese National Intellectual Property Administrant for Its "Abuse and Misuse Deterrent Transdermal System" Application

Recent Filings

• 02.12.2025 - 8-K Current report
• 02.12.2025 - EX-99.1 EX-99.1
• 01.29.2025 - 8-K Current report
• 12.30.2024 - 8-K Current report
• 12.30.2024 - EX-99.1 EX-99.1
• 12.16.2024 - DEF 14A Other definitive proxy statements
• 12.04.2024 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 12.02.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.29.2024 - 4 Statement of changes in beneficial ownership of securities
• 11.29.2024 - 4 Statement of changes in beneficial ownership of securities